---
document_datetime: 2026-01-27 16:22:30
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/emgality-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: emgality-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.6965722
conversion_datetime: 2026-02-01 20:38:54.443029
docling_version:
  docling-serve: 1.11.0
  docling-jobkit: 1.9.1
  docling: 2.71.0
  docling-core: 2.62.0
  docling-ibm-models: 3.11.0
  docling-parse: 4.7.3
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Emgality

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number     | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|------------------------|----------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Variation type IA_IN / | A. ADMINISTRATIVE CHANGES - A.1 Change | 27/01/2026                          |                                             | SmPC,                            |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000315519                     | in the name and/or address of the marketing authorisation holder - Accepted                                                                                                                                                                                                                                                         |            |     | Labelling and PL   |                  |
|---------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|--------------------|------------------|
| Variation type IB / EMA/VR/0000300679 | B.II.b.5 Change to in-process tests or limits applied during the manufacture of the finished product - B.II.b.5.c Deletion of a non-significant in-process test - Accepted                                                                                                                                                          | 14/11/2025 | N/A |                    |                  |
| Article 61(3) /                       | - Notification acc. Article 61(3) - Accepted Update of the package leaflet with revised contact details of local representative and deletion of 'United Kingdom (Northern Ireland)' from the list of local representatives in line with the QRD template v10.4.                                                                     | 09/10/2025 |     | PL                 | EMA/N/0000303559 |
| Variation type IA / EMA/VR/0000295225 | B.II.b.5 Change to in-process tests or limits applied during the manufacture of the finished product - B.II.b.5.c Deletion of a non-significant in-process test - Refused                                                                                                                                                           | 09/09/2025 | N/A |                    |                  |
| Variation type IB / EMA/VR/0000267327 | C.I.11 Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the risk management plan - C.I.11.z Change in due date for category 1, 2 or 3 studies in the RMP and/or Annex II - Accepted C.I.11.z - to request a deadline extension of category 3 study Study I5Q-MC-B003 (B003) | 27/05/2025 | N/A |                    |                  |

<div style=\"page-break-after: always\"></div>

| from 'Q4 2025' to 'Q4 2027' to fulfill MEA 2.2 request. In addition, the MAH took the opportunity to update the wording on study progress reports in the EU RMP.   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|